- Home
- GWH vs CVKD Comparison
GWH vs CVKD Comparison
Compare GWH & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GWH
- CVKD
- Stock Information
- Founded
- GWH 2011
- CVKD 2022
- Country
- GWH United States
- CVKD United States
- Employees
- GWH N/A
- CVKD N/A
- Industry
- GWH Industrial Machinery/Components
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- GWH Miscellaneous
- CVKD Health Care
- Exchange
- GWH Nasdaq
- CVKD Nasdaq
- Market Cap
- GWH 25.3M
- CVKD 29.5M
- IPO Year
- GWH N/A
- CVKD 2023
- Fundamental
- Price
- GWH $1.90
- CVKD $10.45
- Analyst Decision
- GWH Hold
- CVKD Strong Buy
- Analyst Count
- GWH 5
- CVKD 1
- Target Price
- GWH $2.10
- CVKD $32.00
- AVG Volume (30 Days)
- GWH 526.6K
- CVKD 27.7K
- Earning Date
- GWH 08-13-2025
- CVKD 08-11-2025
- Dividend Yield
- GWH N/A
- CVKD N/A
- EPS Growth
- GWH N/A
- CVKD N/A
- EPS
- GWH N/A
- CVKD N/A
- Revenue
- GWH $4,155,999.00
- CVKD N/A
- Revenue This Year
- GWH $124.62
- CVKD N/A
- Revenue Next Year
- GWH $245.00
- CVKD N/A
- P/E Ratio
- GWH N/A
- CVKD N/A
- Revenue Growth
- GWH N/A
- CVKD N/A
- 52 Week Low
- GWH $0.76
- CVKD $5.70
- 52 Week High
- GWH $11.58
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- GWH 53.73
- CVKD 38.03
- Support Level
- GWH $1.76
- CVKD $11.25
- Resistance Level
- GWH $2.04
- CVKD $11.88
- Average True Range (ATR)
- GWH 0.27
- CVKD 0.70
- MACD
- GWH 0.01
- CVKD -0.04
- Stochastic Oscillator
- GWH 42.78
- CVKD 5.78
About GWH ESS Tech Inc.
ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.